STAT
MAY 7, 2024
At the end of February 1960, my healthy, precocious sister Marcie was halfway through the fourth grade when she contracted measles from a classmate who lived down the street. Their cases were among the nearly 500,000 that year , before the measles vaccination program began in the U.S. in 1963. For every 1,000 people who get measles, one develops measles encephalitis , which can cause permanent brain damage.
PharmaVoice
MAY 7, 2024
The director of the University of Pittsburgh’s McGowan Institute for Regenerative Medicine believes the industry is “turning a corner.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
MAY 7, 2024
A young boy died in a trial for Pfizer’s experimental gene therapy for Duchenne muscular dystrophy, the company told patient advocates Tuesday. The boy was enrolled in Daylight, a trial studying the treatment in boys aged 2 or 3. The boy had received the therapy early last year, Pfizer told the advocates in a note posted online by Parent Project Muscular Dystrophy.
BioPharma Dive
MAY 7, 2024
Pfizer said the patient, a young boy who was treated earlier last year, had died suddenly. The company is working with trial researchers to investigate further.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
MAY 7, 2024
Jeremy Farrar, now the World Health Organization’s chief scientist, was working in Vietnam 20 years ago when the H5N1 virus started to spread across Asia — at that point in poultry. He recalls there was a reluctance among farmers to cull their chickens because they weren’t being compensated for them. Movement of infected birds to evade culling only served to disseminate the virus, which in the years since has spread to all continents except Australia.
pharmaphorum
MAY 7, 2024
The life sciences sector in Ireland is booming thanks to nurturing talent and fostering innovation. Companies like Eli Lilly and Regeneron have major operations driving excellence.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
pharmaphorum
MAY 7, 2024
Understanding complex scientific studies is often a challenge for patients as well as healthcare professionals, but one that may become easier thanks to artificial intelligence.
STAT
MAY 7, 2024
When patients are dealing with a sexually transmitted infection, they don’t always get advice on whether they should come into the clinic in a timely fashion. So patient interface company Healthvana created a conversational AI chatbot to quickly answer some of their questions. It had two options: standard AI persona or a drag queen. As it turned out, the rainbow-colored drag queen helped engage more patients.
Express Pharma
MAY 7, 2024
The US has once again pulled up India for ‘inadequate IP enforcement’ India is one of seven countries to remain on the Priority Watch List of the annual “Special 301 Report” recently released by the US Trade Representative (USTR). The other six countries on the Priority Watch List are Argentina, Chile, China, Indonesia, Russia, and Venezuela.
STAT
MAY 7, 2024
A new bill set to be considered on Wednesday by the House Ways & Means Committee would extend for two years telehealth flexibilities for Medicare enrollees that were adopted during the Covid-19 pandemic, and look to reform drug industry middlemen to pay for it. At the end of the official public health emergency, Congress extended flexibilities that changed where and what kinds of care people could receive over telehealth, but those rules are set to expire at the end of the year.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
The Guardian - Pharmaceutical Industry
MAY 7, 2024
Pharmaceutical company says newer shots led to decline in demand for AstraZeneca vaccine, which is no longer being manufactured or supplied AstraZeneca has begun the worldwide withdrawal of its Covid-19 vaccine due to a “surplus of available updated vaccines” that target new variants of the virus. The announcement follows the pharmaceutical company in March voluntarily withdrawing its European Union marketing authorisation , which is the approval to market a medicine in member states.
STAT
MAY 7, 2024
Dear Readers, We are enormously proud that STAT reporters Casey Ross and Bob Herman have been named finalists for the Pulitzer Prize in the investigative reporting category “for exposing how UnitedHealth Group, the nation’s largest health insurer, used an unregulated algorithm to override clinicians’ judgments and deny care, highlighting the dangers of AI use in medicine.
Pharma Times
MAY 7, 2024
The chronic brain disease that causes seizures currently affects around 600,000 people living in the UK
STAT
MAY 7, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, incredibly exciting news from the STAT newsroom — two of our reporters, Casey Ross and Bob Herman (or as we call them, Bob Ross ), were named Pulitzer finalists in investigative reporting!
pharmaphorum
MAY 7, 2024
Pfizer has paused dosing in a study of its Duchenne muscular dystrophy gene therapy after a sudden patient death in another trial
STAT
MAY 7, 2024
Drug development is essentially a long, expensive bet: 90% of drugs fail during clinical trials, goes one of the life science industry’s most oft-quoted statistics. But new ways of identifying and testing therapies, a more precise understanding of disease, and a renewed sense of urgency to address longstanding public health issues could change that dynamic, life science leaders argued this week.
pharmaphorum
MAY 7, 2024
Two-year data from a phase 1/2 trial of eyeDNA Therapeutics' gene therapy for retinitis pigmentosa sets up pivotal trials, says the new biotech.
STAT
MAY 7, 2024
In the second-largest fine ever levied on a pharmaceutical company, Endo Health Solutions was ordered to pay nearly $1.1 billion in criminal penalties and another $450 million in criminal forfeiture for illegally marketing its Opana ER prescription opioid. The company, which last month pleaded guilty to a misdemeanor, admitted that, from April 2012 through May 2013, some of its sales representatives marketed its medicine, also known as oxymorphone, to doctors by touting the drug as abuse deterre
PioneerRx
MAY 7, 2024
It’s one thing to open a pharmacy. Running it is another. But winning your staff over? That’s a whole can of worms. Winning over your pharmacy staff.
STAT
MAY 7, 2024
Top of the morning to you, and a fine one it is. There is nothing like being greeted with clear blue skies and cool breezes upon waking up today on the Pharmalot campus. Birds are chirping, butterflies are flurrying, and official mascots are barking. And we are similarly engaged in early-in-the-day rituals of our own — firing up the trusty coffee kettle for another cup of stimulation.
Drug Channels
MAY 7, 2024
It's time for Drug Channels ’ annual update of vertical integration among insurers, PBMs, specialty pharmacies, and providers within U.S. drug channels. Below you’ll find our latest illustration of the major vertical business relationships among the largest companies along with some of the notable activity since our previous update. These organizations continue to exert greater control over patient access, sites of care/dispensing, and pricing, although some have started to unwind their vert
STAT
MAY 7, 2024
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET. It took decades for scientists to come up with treatments that could slow the progression of Alzheimer’s disease. Now patients and physicians face a new challenge: actually getting the medicines to people who might benefit from them. Join us for a conversation with a practicing neurologist, neuroscientist and geriatrician about overcoming current hurdles involved in diagnosing, treating, and monitoring pa
Pharma Times
MAY 7, 2024
The rare and fatal progressive neurodegenerative disease is estimated to affect 5,000 people in the UK
Pharmaceutical Technology
MAY 7, 2024
AstraZeneca has concluded an equity investment in clinical-stage biotechnology company Cellectis following a deal signed in November 2023.
Outsourcing Pharma
MAY 7, 2024
PCI Pharma Services, a global leader in contract development and manufacturing, has embarked on the installation of crucial equipment for its latest sterile fill-finish facility at its Bedford, NH campus in Philadelphia.
Pharmaceutical Technology
MAY 7, 2024
A new study has further supported psilocybin's potential to treat depression, which impacts around 300 million people globally.
Pharmaceutical Commerce
MAY 7, 2024
The acquisition, the parties say, will benefit pharma and biotech in the clinical and commercial stages.
European Pharmaceutical Review
MAY 7, 2024
A novel intravesical targeted drug delivery system for patients with bladder cancer has demonstrated positive data in updated results from a Phase I trial. Johnson & Johnson’s Phase I study is assessing the safety and efficacy of TAR-210 as a delivery method for sustained, local release of erdafitinib into the bladder. The treatment is being evaluated in patients with non–muscle-invasive bladder cancer (NMIBC) with select FGFR alterations.
The Pharmacist
MAY 7, 2024
Patients from the most deprived populations in England are 21% less likely to be referred through the urgent suspected cancer pathway than those from more affluent areas, a recent report has warned. Responding to the findings, the Royal Pharmaceutical Society (RPS) and the chief executive of the Company Chemists’ Association (CCA) highlighted the ‘positive role’ […] The post Pharmacies could play ‘positive role’ in early cancer diagnosis in deprived areas appeared first on The Pharmacist.
European Pharmaceutical Review
MAY 7, 2024
Two new formulations cabotegravir (cabotegravir extended-release injectable suspension and tablets) have been approved by the Medicines and Healthcare products Regulatory Agency ( MHRA ). The treatment consists of Apretude 30mg film-coated tablets and Apretude 600mg prolonged-release suspension for injection. These treatments are indicated for the prevention of sexually transmitted HIV-1 infection — pre-exposure prophylaxis (PrEP) in adults and adolescents weighing at least 35kg with a higher in
Outsourcing Pharma
MAY 7, 2024
Walgreens and Boehringer Ingelheim have joined forces in a move to enhance diversity and accessibility in clinical trials, aiming to make participation more inclusive and equitable.
World Pharma News
MAY 7, 2024
Novartis announced that it has entered into an agreement to acquire Mariana Oncology, a preclinical-stage biotechnology company based in Watertown, Massachusetts focused on developing novel radioligand therapies (RLTs) to treat cancers with high unmet patient need. The transaction bolsters the Novartis RLT pipeline and expands the company's research infrastructure and clinical supply capabilities, supporting Novartis strategic priorities in oncology and RLT platform innovation.
pharmaphorum
MAY 7, 2024
Having two copies of the ApoE4 gene is not just a risk factor for the development of Alzheimer’s, but is a likely cause of the disease, according to researchers in Spain
European Pharmaceutical Review
MAY 7, 2024
A new report by MarketsandMarkets has predicted that the injectable drug delivery market will reach an 8.6 percent compound annual growth rate (CAGR) between 2024 to 2029. The market is anticipated to value $1139.4 billion by 2029. Injectable drugs are adopted widely as treatments for chronic infections such as HIV/AIDS and tuberculosis (TB). Treatment approaches for the latter condition is often a combination of oral antibiotics plus injectable drugs such as rifampin, isoniazid, and streptomyci
pharmaphorum
MAY 7, 2024
GSK commits to further support of BioVersys’ TB drug Phil.
Expert insights. Personalized for you.
363 
Let's personalize your content